Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review

REFERENCES

1. 1.↵
   1. Langlois V,
   2. Gillibert A,
   3. Uzunhan Y, et al.

   Rituximab and cyclophosphamide in antisynthetase syndrome-related interstitial lung disease: an observational retrospective study. J Rheumatol 2020;47:1678-86.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Arnold J,
   2. Winthrop K,
   3. Emery P.

   COVID-19 vaccination and antirheumatic therapy. Rheumatology 2021;60:3496-502.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Sun S,
   2. Chen Z,
   3. Zhang D, et al.

   Description and analysis of a novel subtype of the anti-synthetase syndrome characterized by frequent attacks of fever and systemic inflammation in a single-center cohort study. Front Immunol 2021;12:729602.

   OpenUrl
4. 4.↵
   1. Cavalli G,
   2. Farina N,
   3. Campochiaro C, et al.

   Repurposing of biologic and targeted synthetic anti-rheumatic drugs in COVID-19 and hyper-inflammation: a comprehensive review of available and emerging evidence at the peak of the pandemic. Front Pharmacol 2020;11:598308.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. van Tassell BW,
   2. Abouzaki NA,
   3. Erdle CO, et al.

   Interleukin-1 blockade in acute decompensated heart failure: a randomized, double-blinded, placebo-controlled pilot study. J Cardiovasc Pharmacol 2016;67:544-51.

   OpenUrl
6. 6.↵
   1. Aggarwal R,
   2. Rider LG,
   3. Ruperto N, et al.

   2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol 2017;69:898–910.

   OpenUrl
7. 7.↵
   1. Furlan A,
   2. Botsios C,
   3. Ruffatti A,
   4. Todesco S,
   5. Punzi L.

   Antisynthetase syndrome with refractory polyarthritis and fever successfully treated with the IL-1 receptor antagonist, anakinra: a case report. Joint Bone Spine 2008;75:366-7.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Zong M,
   2. Dorph C,
   3. Dastmalchi M, et al.

   Anakinra treatment in patients with refractory inflammatory myopathies and possible predictive response biomarkers: a mechanistic study with 12 months follow-up. Ann Rheum Dis 2014;73:913-20.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Meudec L,
   2. Jelin G,
   3. Forien M,
   4. Palazzo E,
   5. Dieudé P,
   6. Ottaviani S.

   Antisynthetase syndrome and cardiac involvement: a rare association. Joint Bone Spine 2019;86:517-8.

   OpenUrl
10. 10.↵
    1. Ahmad N,
    2. Parmar A,
    3. Kitchen J.

    A case of macrophage activation syndrome in a patient with anti-synthetase syndrome. Oxf Med Case Reports 2021;2021:omab045.

    OpenUrl